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ABSTRACT 
Introduction:  
Febrile convulsions are one of the common paediatric emergencies encountered 
around the world. Febrile seizures occur in 6 months to 5 years of age group. 
Incidence of febrile convulsions around the world is between 3-4%.  It is of 
similar incidence all over the world.Various risk factors were proposed for 
development of febrile seizures like developmental delay, >30 days of NICU 
stay, febrile convulsion history in the family, viral infections, iron and zinc 
deficiencies. Role of Zinc and iron deficiency in febrile convulsions were 
studied in western countries. But in India, there are very few studies. In this 
study we are proposing that low Zinc and Iron levels may predispose to 
development of febrile seizures. 
Aim: To estimate serum Zinc and iron levels in children with febrile seizures 
and compare this values with febrile children without seizures. 
Materials and Methods:  
It is a case control study. The study group includes 50 cases (febrile 
seizures) and 50 controls (fever without seizures) aged 6months to 5 years (6-60 
months) attending paediatric out-patient department or admitted in PSG hospital 
who fulfilled the inclusion criteria. Children who are having atypical febrile 
seizures, intracranial infections, on Zinc and iron supplementation, electrolyte 
and metabolic disorders were excluded from the study. Informed and written 
consent was obtained from cases and controls. Temperature was recorded in 
Fahrenheit by using digital thermometer. 3-5ml of blood was collected from 
peripheral line in a red colour container. Serum was separated by centrifugation 
and stored at -20°C until serum zinc and iron levels were measured. Zinc and 
Iron levels were estimated by Atomic Absorption Spectroscopy in Stanes 
laboratory, Coimbatore.Categorization of socioeconomic status was done by 
modified Kuppuswamy scale, 2012.Nutritional status of all cases and controls 
were assessed according to IAP classification of malnutrition. Data was 
analysed using SPSS software. Methods like Chisquare and T-test were used. 
Results:  
Mean serum Zinc, Iron, haemoglobin, MCV, MCH, RDW levels were 
significantly low in cases when compared with controls (p-value 
<0.0001).Mean serum zinc was almost similar in <24 months and >24 months 
age group. Mean serum Iron and other red cell indices were low in <24 months 
group when compared with >24 months age group. Odds ratio was 68.3 if 
patient having both Iron and zinc deficiency. 
Conclusions: Iron and zinc levels were significantly low in children with febrile 
seizures when compared to febrile children without seizures.Serum Iron was 
very much low in children < 2years of age when compared to > 2years of 
age.There is no age wise difference in mean Zinc levels. There was 68.3 times 
increased risk of developing seizures, if they were having both low Iron and 
Zinc levels. 
Key words: Febrile seizures, Hemoglobin, MCV, MCHC, RDW, WHO, India, 
Iron deficiency, Risk. Zinc deficiency  
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INTRODUCTION 
 Febrile convulsions are one of the common paediatric emergencies 
encountered around the world. Febrile seizures occur in 6 months to 5 years of 
age group. According to American Academy of Paediatrics, febrile convulsions 
is defined as febrile seizures occur in the absence of intracranial infection, 
metabolic disturbance or history of afebrile seizures, and are classified as simple 
or complex[1,2]. 
Incidence of febrile convulsions around the world is between 3-4%.  It is 
of similar incidence all over the world. At least 3-4 % children may have one 
episode below 5years of age. In India, incidence is almost 10% according to 
some studies. But recent studies indicate that incidence is almost comparable to 
western population[3].  
Aetiology of febrile seizures was still unclear. Various hypotheses like 
genetic susceptibility, hyperthermia induced convulsions were proposed. Still 
the pathogenesis remains inconclusive.  Various risk factors were proposed for 
development of febrile seizures like developmental delay, >30 days of NICU 
stay, febrile convulsion history in the family, viral infections, iron and zinc 
deficiencies[1,4].  
In brain, zinc is present in large quantities in the hippocampus. Zinc 
regulates glutamic acid decarboxylase activity which is an important enzyme in 
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production of γ- amino butyric acid. It also regulates the neurotransmitter 
affinity. It mediates inhibition of calcium on N-methyl-D-aspartate receptors 
there by reducing excitatory discharge of neurons. In deficiency of zinc, these 
receptors get stimulated which may produce epileptiform discharges in children 
with fever[5].  
 
Zinc also activates pyridoxal kinase, which in turn helps in the pyrioxal 
phosphate synthesis from pyridoxal. Pyridoxal phosphate inturn activates 
glutamic acid decarboxylase which involved in synthesis of GABA. Post 
synaptic receptors in interaction with zinc assists in GABA action. Hence 
hypozincemia leads to decrease in GABA level which leads to development of 
seizures[5]. 
 
Iron is an important element for metabolism in the brain. It also helps in 
neuro transmitter metabolism. Deficiency of iron acts as an important factor in 
development of febrile seizures[6]. Role of Zinc and iron deficiency in febrile 
convulsions were studied in western countries. But in India, there are very few 
studies. In this study we are proposing that low Zinc and Iron levels may 
predispose to development of febrile seizures.  
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AIMS AND OBJECTIVES 
• To estimate serum Zinc and iron levels in children with febrile seizures. 
• To compare this values with febrile children without seizures. 
 
Inclusion Criteria:   
1) Children between 6months to 5years. 
2) Seizure occurs within 24 hrs of fever and lasts for < 15mins. 
3) Generalized seizures. 
4) No post ictal deficit. 
Exclusion Criteria:  
1) Atypical febrile seizures. 
2) Children with documented intracranial infections. 
3) Children on zinc and iron supplementation for therapeutic purpose. 
4) Electrolyte imbalance. 
5) Hereditary metabolic disorders. 
6) Structural brain lesions. 
7) Children with cerebral palsy,mental retardation and,neuro 
degenerative disorders. 
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MATERIAL AND METHODS 
The study group includes 50 cases (febrile seizures) and 50 controls (fever 
without seizures) aged 6months to 5 years (6-60 months) attending paediatric 
out-patient department or admitted in PSG hospital who fulfilled the inclusion 
criteria. Children who are having atypical febrile seizures, intracranial 
infections, on Zinc and iron supplementation, electrolyte and metabolic 
disorders were excluded from the study. Informed and written consent was 
obtained from cases and controls. Temperature was recorded in Fahrenheit by 
using digital thermometer. All these children have normal central nervous 
system examination. Complete blood count was done in all patients. 3-5ml of 
blood was collected from peripheral line in a red colour container. Serum was 
separated by centrifugation and stored at -20°C until serum zinc and iron levels 
were measured. Zinc and Iron levels were estimated by Atomic Absorption 
Spectroscopy (Agilent Technologies 200 series AA) in Stanes laboratory, 
Coimbatore.  
 Sociodemographic factors like occupation, family monthly income, and 
educational status were collected from parents. Categorization of 
socioeconomic status was done by modified Kuppuswamy scale, 2012. 
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MODIFIED KUPPUSWAMY SCALE: 
EDUCATION 
Profession or honors      7 
Graduate or post graduate     6 
Intermediate or post high school diploma   5 
High school certificate      4 
Middle school certificate      3 
Primary school certificate      2 
Illiterate        1 
OCCUPATION 
Profession        10 
Semi-profession       6 
Clerical, shop owner, Farmer     5 
Skilled worker       4 
Semi-skilled worker      3 
Unskilled worker       2 
Unemployed       1 
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FAMILY INCOME PER MONTH (in Rs) 2012 June 
>31507                                                                             12 
15754 – 31506                                                                 10 
11817 - 15753                                                                   6 
7878 – 11816                                                                    4 
4727 – 7877                                                                      3 
1590 – 4726                                                                      2 
<1589                                                                                1 
 
TOTAL SCORE                                           SOCIO ECONOMIC CLASS 
26-29                                                              Upper (I) 
16-25                                                              Upper middle (II) 
11-15                                                              Lower middle (III) 
5-10                                                                Upper lower (IV) 
<5                                                                   Lower (V) 
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Weight and height were measured from cases and controls. Nutritional status of 
all cases and controls were assessed according to IAP classification of 
malnutrition[7]. Data was analysed using SPSS software. Methods like 
Chisquare and T-test were used. 
FIGURE 1: 
 
Study area: PSG Hospitals, Coimbatore. 
Study design:Case control study. 
Sample size:50 cases and 50 controls. 
  Withan expected correlation between serum Zinc and Iron levels with 
febrile seizures as (r = -0.86) reference (LusianaMargaretha, 
NurhayatiMasloman, Correlation between serum zinc level and simple 
febrile seizure in children. PaediatrIndones 2010;50(6):326-30). And with α 
= 0.05 and 80% power, the sample size required is n = 9. With 20% non-
response,Therequired sample size in each arm as 12. 
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Study population:Children aged between 6 months to 60 months (5 years) 
with fever with or without seizures. 
 
Analysis of Zinc in Plasma by Atomic Absorption Spectroscopy (Agilent 
Technologies 200 series AA:   
Figure 2: 
 
Blood Collection and Processing of Samples:  
Collected1mL of whole blood by venepuncture, using all-plastic polyethylene 
syringes and stainless steel needles with polypropylene infusion set shown to 
contribute non-detectable amounts of zinc. Then two drops (50 µL) of a 300 g/L 
sodium citrate solution was added into the centrifuge tubes before collecting the 
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specimen of blood.  Centrifuged the blood immediately at 1000 x g for 15 min, 
and transferred it. Separated the plasma from the cells and transferred, into 
polyethylene storage vials, taking care to prevent disruption of the buffy coat or 
packed cells,  because these cells can introduce relatively high amounts of 
cellular zinc into the plasma and hence all haemolysed samples was discarded. 
The samples were stored at -20°C. 
 
Reagents and Materials:  
1.Standards :  Zinc standards (Merck solution traceable to SRM from NIST at 
0.2-1ug/ml  were prepared by diluting the stock standard solution, for zinc, with 
5% (v/v) glycerol and  the same 5% (v/v) glycerol solution was used as a blank 
solution when determining zinc. The working standards, 100, 200, 300 and 400 
µg of zinc per litre were prepared. Delivered 1 mL of 1000 mg/L zinc standard 
into a 100 mL volumetric flask and dilute to volume with glycerol/water 
solution (95:1) and it was mixed by inverting. Placed the aliquots of this 
intermediate stock (1, 2,3, and 4mL) into four 100 mL volumetric flasks and 
diluted to volume with the glycerol/water mixture.  The standards (0.1, 0.2, 0.3 
and 0.4mg of zinc per litre) corresponded, to apparent plasma zinc 
concentrations of 500, 1000, 1500 and 2000 µg of zinc per litre. We 
shouldpreparea working curve from fresh standards, before each test. 
Calculatethe concentration of zinc in the plasma directly from the curve.   
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2. Glycerol solution:  Diluted 50mL of glycerol to 1000 mL with de-ionized 
water.  Glycerol, certified ACS (99.4%), was Fisher Scientific Co., and all 
volumetric glassware must meet NBS Class A specifications.  Glassware and 
Pasteur pipettes are acid washed, soaked in disodium 
ethylenediaminetetraacetate (EDTA) solution (1%) for 24 h and rinsed with de-
ionized water.   
3. Serological pipettes and tubes:  The disposable serological pipettes and 
polystyrene tubes used in this study contributed no detectable zinc to the sample 
and therefore required no pre-treatment. 
4. Pooled plasma for quality control:  Pooled plasma can serve as a reference to 
monitor inter-day reproducibility.  Plasma is ideally obtained as a large single 
specimen from a normal healthy individual.  Control plasma should be negative 
for and free of haemolysis.  We should storein 1mL portions in individual 
polyethylene vials at -20°C.  Thawed an aliquot at room temperature and 
analyzed it with the plasma samples. 
5. Sample preparation for analysis: For the determination plasma zinc, the 
samples were diluted in the ratio of 1:5 with deionized water 
6. Methodology:  For The determination of zinc in blood plasma samples 
diluted with deionized water was carried out after appropriate dilution with a 
minimum of 0.2-1.0 mL serum sample, with an equal volume of a 20% (w/v) 
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TCA solution. The analysis is performed against standards prepared in glycerol 
to approximate the viscosity characteristics of the diluted samples. 
Allowed the plasma samples to come to room temperature and then 
mixed each sample by gently inverting the tube six times.  Prepare working 
standards as previously described.  Deliver 0.5 mL of plasma sample with a 
serological pipette into a 16 mm plastic test tube.  Add 2.0 mL of de-ionized 
water and immediately mix the solution for 30s.  Repeat for plasma samples in 
groups of 10.  Similarly prepare a control sample of pooled plasma.   
 
The instrumental and gas-flow settings and aspiration rate is set precisely, to 
optimize signal and minimize background noise.  The instrumental settings 
shown apply to the instrument, used in this study.  Once the aspiration rate is 
optimized with 10 mL aliquots of water, the nebulizer flow adjustment is locked 
in place.  Aspirated glycerol/water solution (5/95 by vol) into the luminescent 
flame and the baseline was set to read 0.000±0.001 absorbance (A).  The 
baseline reading was taken before and after each sample and the baseline was 
reset as required.   
 
The zinc working standards was sampled sequentially from most dilute to most 
concentrated, aspirating until the reading is stable (±0.001 absorbance); then 
record six successive 1-s integration readings.  Average the readings for each 
sample; the resulting values are used to establish the working curve, preferably 
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by use of a regression least squares fit.  Mix again and aspirate standardized 
pooled plasma sample.  Calculate the concentration from absorbance readings 
by interpolation from the working curve. Results must be within 20µg/L 
(ca.3%) and the mean was previously established.   
Normal zinc levels are 60-120µg/dl. 
 Analysis of Iron in Plasma by Atomic Absorption Spectroscopy (Agilent 
Technologies 200 series AA):   
The above methodology was adopted for analysing Iron.  
Sample Preparation: To estimate the total serum iron, samples were diluted 
1:2 with a 20% (w/v) trichloroacetic acid solution, and heated.  This procedure 
precipitates the plasma protein and removes approximately 95% of any 
haemoglobin iron present. Diluted 0.2- 0.5 mL of serum sample with an equal 
volume of a 20% (w/v) TCA solution in a polyethylene tube,.  The tube was 
capped loosely, mixed and heated in a heating block at 90°C for 15 minutes.  
The sample was cooled and centrifuged. The haemolysed samples are generally 
discarded, even though the TCA removes about 95% of haemoglobin iron.Iron 
standards (Merck solution traceable to SRM from NIST at 0.5-1ug/ml) 
standards are prepared by diluting the iron stock solution with 10% (w/v) TCA.  
A 10% (w/v) TCA solution was used for the blank. Since the samples are 
diluted 1:2 with TCA, the instrument was calibrated to read as dilution factor x 
the actual concentration of the standards, so as to be able to read concentration 
directly. Normal iron levels were 65-120µg/dl. 
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REVIEW OF LITERATURE 
Febrile seizures: 
History:  
In 460-370 BC, Hippocrates wrote that, seizures are commonly seen in the 
presence of acute onset of fever. He also described that seizures will be present 
up to 7th year of life. Children crossed 7th year of life and adults are not 
susceptible to convulsions, until there are other symptoms. He described that 
brain is important site of these seizures. he also described that many patients 
suffering from this disease will be safe but with very little damage[2] 
Until 1950s, they were not identified as separate entity different from 
epilepsies. Livingstone classified this condition into fever triggered epilepsy and 
simple febrile seizures. He defined fever triggered epilepsy as “febrile seizures 
that were of focal or of longer duration and also having family history of 
epilepsy”[8]. 
Terminology  
Epilepsy[9]: 
Epileptic seizure is a transient occurrence of signs or symptoms due to abnormal 
excessive or synchronous neuronal activity in the brain 
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Status epilepticus[9]: 
A single seizure lasting more than 30 minute duration or a series of epileptic 
seizure during which function is not regained between ictal events in a > 30 min 
period. 
Definition of febrile seizure[3]: 
 According to National institute of health, febrile convulsions is defined as 
an event occurs in infancy or childhood occurring between 1 month and 5 years 
of age, associated with fever but without evidence of intracranial infection 
(USA 1980). 
 According to international league against epilepsy, febrile convulsion is 
defined as convulsion occurring between 1 month and 5 years of age, associated 
with a febrile illness not caused by an infection of CNS without previous 
neonatal seizures or a previous unprovoked seizure and not meeting criteria for 
other acute symptomatic seizures (1993) 
American academy of pediatrics definition[1] 
According to Americsn academy of paediatrics, febrile seizures occur in the 
absence of intracranial infection, netabolic disturbance or history of afebrile 
seizures, and are classified as simple or complex. 
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Epidemiology  
 In childhood, febrile convulsions are very common. Incidence of febrile 
seizures in United States of America and European countries is 2-4%[1,2]. 
According to previous studies, febrile seizure was seen in almost 10% of Indian 
children. But current studies showed similar incidence rates when compared to 
USA and Europe[3].  
Age: 
Febrile convulsions are most commonly occurs between 6months to 
5years. Age of onset of febrile seizures in most of the cases is 18 months. 
Almost ½ of the febrile convulsion patients, onset of seizures is between 1- 2 
years[4]. Recurrent febrile convulsions are seen in those initial seizure occurs < 
1 year of age. Above 6 years and below 6months, chance of febrile seizure is 
very minimal or negligible[1]. 
Relationship between incidence of febrile seizures and age is improperly 
understood. In younger age group, brain is comparatively immature. Hence in 
response to fever, there will be increased excitability of  neurons which may 
lead to febrile seizure[10]. 
Sex:  
Girls are less commonly affected than boys. In almost all studies 
Male/Female ratio is ranging from 1.1:1 to 4:1[10]. 
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Maternal risk factors: 
Berg described that smoking and gastroenteritis in pregnancy are 
important risk factors for febrile convulsions[11]. In contrary a case control 
study conducted in Sweden which was community based showed no significant 
increase in occurrence of febrile seizures in the presence of antenatal or 
maternal risk factors[10]. 
Perinatal risk factors: 
 According to some studies, complications like prolonged labour and 
perinatal asphyxia, prematurity implicated as important factors in occurrence of 
febrile convulsions.[11] 
According to a study conducted by Zwaini et al, perinatal asphyxia or 
gestational age were not considered as risk factor for febrile seizures. Many 
studies proved that NICU stay of more than 30 days considered as significant 
factor for development of febrile convulsion[10].  
Family history: 
It is already an established entity that febrile convulsions run in families. 
Both parents can transmit this to their children. In children with febrile 
convulsions, 25-40% will have strong family history of febrile convulsion. In 
siblings, frequency ranges between 9-22%. According to various studies, risk of 
developing febrile convulsion doubles, if both parents had febrile seizures rather 
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than single parent[3]. In twin studies, for monozygotic twins concordance rate 
was 35% and for dizygotic twins it is 15%[12]. 
 1 out of 33 children in the population may have febrile seizures. After an 
effected child, risk of occurring in next sibling is 20% (1 out of 5). Risk 
increases to 1 out of 3, if previous child and both mother and father had history 
of febrile seizures. Only one out of ten may proceed to afebrile seizures which 
are recurrent[13,14]. Many studies concluded that inheritance for febrile seizure 
susceptibility is polygenic and very rarely autosomal dominant[3,15]. 
Genetic factors: 
 Various models have been proposed. Universally accepted models are 
polygenic, autosomal dominant, and a multifactorial model. Complex 
segregation analysis was done by Rich et al through febrile seizures pro-bands 
in 467 families. They confirmed that polygenic model of inheritance was seen 
in these families with single episode of febrile seizure[15]. 
 In families with multiple febrile seizure episodes, model proposed was 
single major locus model. In families with 52 febrile seizure pro-bands, Johnson 
et al. conducted a pedigree study. They confirmed that autosomal dominance 
with decreased penetrance was seen in these families[15,16].  
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Febrile seizure phenotypes[15]: 
 Recently Scheffer and Berkovic and Singh et al. termed a subset called 
GEFS+ (generalised epilepsy with febrile seizures plus). In this mode of 
inheritance is autosomal dominance. The term GEFS+ was used when there is 
continuation of fever with seizures in children > 6 years/ associated with non- 
febrile generalised tonic clonic seizures. This was self-limiting condition which 
was resolved by middle of adolescence.  
Phenotype spectrum (Figure 3) 
 
There isassumption that febrile seizures and epilepsy were two different 
entities. But there is considerable overlap in genetics and clinical features 
between febrile seizures and epilepsy. It is possible that susceptible to febrile 
seizures gives rise to epilepsy in later stages of life. 
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Linkage mapping studies[15,17–19]: 
 By various studies, loci for febrile seizures were identified. They are FEB 
1, 2, 3, 4, and GEFS+ locus. 
Figure 4: Febrile seizure loci 
 
Immunisation: 
 Three vaccines are identified as risk factors for febrile convulsions. They 
are MMR vaccine, DPT vaccine, and Influenza vaccine. 
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MMR vaccine: 
Following MMR vaccination, there is transient risk of febrile seizures 
when compared with those who are not vaccinated. The occurrence of febrile 
seizures could be due to fever induced by vaccine. Vestergaard and Hviid et al. 
conducted a large cohort study in Denmark. Out of 439251children who 
received vaccination, 17986 children had single febrile seizure episode. Within 
2 weeks of vaccination, 973 out of 17986 children had febrile seizures[20].  
Griffin et al. found that febrile seizures risk was high with in first 2 week of 
vaccination[21].  
DPT vaccine: 
DPT vaccination was related with increased risk of convulsions and 
encephalopathy. Within 3 days of DPT vaccination, there was increased risk of 
febrile seizures. Barlow et al. conducted a large scale cohort study in USA. Out 
of 340386 DPT vaccination and 137457 MMR vaccinations, 487 children 
developed febrile seizures and 137 children developed afebrile seizures. 
Incidence of febrile seizures following MMR and DPT vaccination found out to 
be 25-30 and 6-9 per 100000 children[21]. 
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Influenza vaccine: 
They found out that there is increased risk of febrile seizures between 6 
months to 4 years with FLUVAX and FLUVAX junior. They found out that 
there are increased rates of fever within 1 day of administration. Incidence of 
febrile seizures after fluvax or fluvax junior found to be ≤9 per 1000. Other 
brands like TIV or LAIV found to be safer and can be administered. According 
to ACIP, Vaccines recommended in the age group between 6 months to 8 years 
are TIV or LAIV[22]. 
Viruses as a precipitating factor: 
 In previous studies, approximately 40 % febrile seizure children have 
various viral infections. Hall et al. reported that 1/3rd of the febrile seizures 
children have Human Herpes Virus 6 infection (HHV-6). HHV-6 found to be an 
important factor for recurrent episodes. Van zeijl et al. reported that risk of 
recurrence is more in children with influenza A. rotaviral gastroenteritis have 
twice the risk of convulsions when compared with other causes[23]. 
 Chung et al. conducted a retrospective study in Hong Kong. In this study 
they reviewed 923 children with febrile seizures. 565 out of 923 children have 
admitted for first episode of seizure. They found out that 163 out of 923 
(17.6%) found to have influenza infection. 63 out of 923 (6.8%) found to have 
adenovirus infection. 55 out of 923 (6%) found to have para influenza infection. 
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25 out of 923 (2.7%) found to have RSV infection. 12 out of 923 (1.3%) found 
to have rotavirus infection. Incidence of influenza, para influenza, adenovirus, 
RSV and rotavirus in febrile convulsions were 20.8%, 20.6%, 18.4%, 5.3%, and 
4.3% respectively[23]. 
Pathophysiology of febrile seizures: 
 Various animal models help in understanding of disease process. Usually 
these models are appropriate for age. Hyper thermic seizure model is a model in 
which outside heat will be used to produce hyperthermia. Heat can be produced 
from heat sources like microwave, heat lamp etc. In “febrile” seizures model, 
endotoxin lipopolysaccharide will be injected which will produce 
immunological reaction and fever[24]. 
Mechanisms of febrile seizures:  
Temperature:   
 If febrile convulsion developed in the presence of low fever, these 
children have higher risk for development of further seizures. This may be 
because of low threshold for convulsions. GABA (A) receptor usually mediates 
excitation or inhibition of neurons. If temperature > 38°c, it reduce the 
inhibition on neurons. Hence it leads to un-opposed excitation of neurons. This 
may produce convulsions[24]. 
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Mediators of inflammation: 
 Cytokines like tumour necrosis factor, interleukins play an important role 
in various neurological diseases. Helminen and Vesikari in 1990 found that an 
increased interleukin 1β production may play an important role in development 
of seizures[24]. In previous studies, they tried to control the seizures with 
paracetamol (antipyretics). But they found out that they are not effective. So 
they tried to examine alternate pathway (effect of cytokine production on 
development of seizures)[25].  
Figure 5:Effect of cytokine production on febrile seizures 
 
In cytokines, interleukin 1β was implicated in pathogenesis of febrile seizures. 
Seizures were produced due to changes in NMDA receptor phosphorylation by 
IL- 1β. Vivianietal.found that there is an increased Ca+2influx. This was due to 
NR2A/B phosphorylation which is a subunit of NMDA receptor[25].  
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Respiratory alkalosis: 
 It is well observed fact that there is increase in respiratory rate whenever 
there is an increase in temperature of the body. So there may be 
hyperventilation in the presence of hyperthermia. In experimental rat models, it 
was proved that hyperventilation may lead to respiratory alkalosis. It may act as 
a triggering factor for development of seizures. Increased atmospheric Co2 to 
5% may result in reduction of convulsions[26].  
Two-Hit hypothesis: 
 According to various studies conducted on rats that have neuronal 
migration disorders, they have lesser threshold for hyper thermic convulsions. 
In later stages they are more prone for temporal lobe epileptic disorder. In brain 
with previous damage, febrile convulsions may produce serious effects than 
normal brain[24]. 
Effects of febrile seizures: 
 According to various studies, febrile convulsions may produce following 
changes. 
Functional changes[24]: 
 According to large cohort study conducted in Denmark, in children with 
febrile convulsion history had 5times more risk of developing afebrile seizures 
in later part of life. But after twenty three years of follow up, <7 % had 
epilepsy. In other studies they reported that there is a possible relation between 
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febrile seizures and temporal lobe epilepsy which is classified under complex 
partial seizures.  
In some prospective studies, they reported that large proportion of 
complex febrile seizures patients may develop epilepsy. But risk is still very 
less. Simple febrile convulsion will not have any effects on behaviour and 
development normally. But if it is occurred below 1st year of age, they may have 
delay in language and development. These children may need to join in special 
schools[24]. 
Changes in structure: 
 There may changes in limbic system in children with febrile seizures. 
MRI may show changes in the hippocampal structure. According to MRI 
studies done in 11 children with febrile status epilepticus, abnormal signal 
intensity in hippocampus seen in 7 children developed within 3 days of seizure. 
During follow up, 5 out of 7 children had mesial temporal sclerosis[24]. 
Molecular changes: 
Hyper thermic seizure was known to alter benzodiazepines and 
GABAbinding to GABA (A). It also decrease the inhibition in the hippocampus 
which is GABA (B) receptor mediated[24]. 
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Clinical features: 
Febrile seizures broadly classified into simple or complex febrile seizures 
Figure 6: Simple Vs complex febrile seizures 
 
In simple febrile seizures there is no post ictal confusion or loss of 
consciousness, whereas in complex febrile seizures there may be post ictal 
confusion[1,4]. Febrile convulsions may present as initial manifestation of a 
fever. Convulsion can be tonic clonic or any other variety. But generalised tonic 
clonic seizures are very common[8].  
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Differential diagnosis[1,4]: 
Figure 7: 
 
Evaluation of a child with febrile convulsion: 
 Evaluation involves history taking, complete physical examination, and 
lab investigations.  
History[8]: 
1) Symptoms of various infections,  
2) Drug usage,  
3) H/o trauma,  
4) Development level, 
5) Family history of febrile or afebrile convulsion 
6) Any recent immunisation history 
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Physical examination:[8] 
1) Consciousness 
2) Examination of all systems 
3) Anterior fontanel – at level/bulging 
4) To look for presence of meningeal irritation. 
5) To look for any focal neurological abnormalities. 
Lab investigations (AAP guidelines): 
Simple febrile convulsions: 
Routine investigations: 
Routine investigations like complete blood count, urine routine and serum 
electrolyteswere not needed until there is suspicion of infection. Presence of 
bacteria in the blood is same in children <2years of age with or without 
convulsions. In some cases there may be electrolyte abnormalities. In those 
cases depends on clinical history and condition of the patient, one should decide 
on doing routine investigations[1,8,27]. 
Indications for Lumbar puncture[1,8,27]: 
1) Lumbar puncture is indicated in a child having signs of meningeal 
irritation. 
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2) Any child between 6months to 1 year with deficient vaccination against 
haemophilus influenza and pneumococcus – lumbar puncture is 
considered optional. 
3) Any child admitted with fever and convulsions and already on antibiotics, 
lumbar puncture is considered optional. 
EEG (Electro Encephalogram)[1,8,27]: 
 In neurologically normal child with simple febrile convulsions, EEG is 
not indicated. In some studies EEG showed paroxysmal findings.  
Neuro imaging[1,8,27]: 
 Neuroimaging like MRI and CT scan will not be indicated in simple 
febrile convulsions. CT scan is associated with exposure to radiation. 
Complex febrile convulsions[1,4,28]: 
Routine investigations: 
 Complete blood count and urine routine are recommended to rule out 
infectious aetiology. Serum electrolytes can be done if we suspect any 
biochemical abnormality. 
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EEG: 
Electroencephalogram is recommended in recurrent episodes of complex febrile 
seizures. EEG is indicated to rule out conditions like encephalitis. 
Lumbar puncture: 
Lumbar puncture should be performed in all children with clinical suspicion of 
CNS infection. 
Neuroimaging: 
CT brain or MRI scan can be done to rule out abnormalities in the brain. 
Shinnar et al. conducted a FEBSTAT study in febrile status epilepticus children. 
They reported that hippocampal abnormalities are seen in 10.5% of the cases. 
7.9% of the status epilepticus children showed extra hippocampal temporal lobe 
abnormalities[29]. 
Figure 8: 
Hippocampal abnormalityExtra hippocampal abnormalities
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Treatment of active seizures: 
Any child arrived to EMD with seizures; we have to treat it as status 
epilepticus unless otherwise proven. 
Figure 9: Management of active seizures 
 
Management and prognosis for simple febrile seizures: 
 Management of simple febrile convulsions includes long term treatment 
or intermittent prophylaxis. 
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Long term treatment[1,4,30,31]: 
 This includes treating these children with long term anti- epileptic drugs. 
Various studies were conducted for effective and safer anti- epileptic to prevent 
further seizures. 
Phenobarbital:  
 Camfield et al. conducted a randomised control trail in 79 children with 
febrile convulsions. In this they have given phenobarbital 5mg/kg/day single 
dose daily or placebo. They found out that recurrence rate came down 
significantly in phenobarbital group than placebo group.  
Adverse effects are  
1) Lethargy. 
2) Hyperactivity. 
3) Sleep disturbances. 
4) Irritability. 
5) Hyper sensitivity. 
6) Short term memory impairment. 
As adverse effects are more than benefits, AAP is not recommended the long 
term management with phenobarbital. 
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Sodium valproate: 
 Mamelle et al found out that phenobarbital was less effective when 
compared with sodium valproate. Fewer studies were done on valproic acid 
safety.  
Adverse effects: 
1) Hepatotoxicity. 
2) Renal toxicity. 
3) Pancreatitis. 
4) Haematological problems. 
There are more adverse effects than benefits. So this drug is also not 
recommended by AAP. 
Primidone: 
 Various Studies found out that 15-20 mg/kg/day of primidone is effective 
in reducing recurrence. But irritability, behavioural problems, sleep problems 
also seen with primidone. Hence it is not recommended. 
Carbamazepine and Phenytoin: 
 Phenytoin and carbamazepine are not effective in reducing the 
recurrence. 
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Intermittent prophylaxis[1,4,14,30,31]: 
 Intermittent prophylaxis includes treatment with antipyretics and anti-
epileptics.  
Antipyretics: 
 Camfield et al found out that 25% of the children had developed 
recurrence with only control of temperature. Schnaiderman et al reported that 
acetaminophen given at 15-20mg/kg/dose Q 4th hourly did not prevent 
recurrence of seizure. AAP is not recommending the use of Antipyretics for 
intermittent prophylaxis. 
Intermittent anti-epileptic prophylaxis: 
Diazepam: 
 Autret et al conducted a randomised control trail. They reported that 
0.2mg/kg of oral diazepam was not effective when compared with placebo 
group. 
Adverse effects of intra nasal, oral or rectal diazepam: 
1) Drowsiness 
2) Lethargy 
3) Respiratory depression 
4) Ataxia  
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AAP is not recommending the use of diazepam as intermittent prophylaxis. 
Clobazam: 
Rose et al conducted a randomised controlled trial. They found that 1.7% 
of 60 patients have recurrence when compared with placebo group. They also 
found that weakness and drowsiness seen equally in both diazepam and 
clobazam group. Ataxia was comparatively lower in clobazam group. They 
concluded that clobazam is safe and effective than diazepam as intermittent 
prophylaxis[32]. 
Prognosis: 
 Febrile convulsions usually carries good prognosis. Physician should 
ensure parents that there are no long term neurological sequelae from febrile 
convulsions. In UK, they conducted a population bases study. They followed up 
381 children prospectively up to 10 years of age. They found out that they 
perform as good as normal children in all aspects[1]. 
 In Denmark, they conducted a cohort study in 1600000 children. They 
found out that there is slight increase in death rate in children with complex 
febrile convulsions (within 2 years). In simple febrile convulsions, there is no 
significant increase in death rate[1,33]. 
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Figure 10: Risk of recurrent febrile convulsion[1,14] 
 
Figure 11: Risk factors for developing epilepsy[1,14] 
 
Zinc (Zn) 
Historical aspects: 
In 1869, importance of zinc was established for plants. In humans, zinc 
importance was established in 1961. In 1961, it was reported that an Iranian 
farmer developed a syndrome of short stature, hypogonadism and anemia who 
was taking unrefined flat bread, potatoes and milk. Similar case reports 
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published on Egyptian adolescents. After 1961, zinc deficiency is known as 
important nutrition problem in the world [34]. 
Zinc is an important trace element among all micronutrients. In 
developing countries, nearly 2 billion people are zinc deficient. Zinc deficiency 
causes increase in diarrhoea and infection leading to death of around 8 lakhs 
children in the entire world. Zinc deficiency is one of the risk factor for 
immunodeficiency and infection susceptibility in older people. Hence dietary 
intake of zinc will have impact on various aspects of human health.[35] 
 
Sources of zinc 
Major animal sources of zinc are oysters, shell fish, lobster, poultry, pork 
and dairy products. Predominant sources of zinc in plants are soy foods, peas, 
nuts, cereals which are fortified, sea vegetables, seeds, beans which are cooked 
and dried. Though zinc is available in large number of edible products, intake of 
easily absorbable zinc (i.e red meat, oysters, liver, mushrooms, crabs and 
poultry) foods is less in most of the developing countries[35].  
Although tubers, legumes, cereals which are staple traditional foods 
contain zinc, the bioavailability in these products is reduced due to formation of 
insoluble complexes with zinc by phytate, lignin and fibres thereby decreasing 
its absorption. Zinc is available in negligible quantities in fruits and 
vegetables[35]. 
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Figure 12: Zinc contents of various foods[36] 
 
Zinc metabolism 
Absorption of zinc[34] 
After dietary intake, it will reach the small intestine where it absorbed by 
carrier mediated transport. Zinc absorption depends on type of feed and amount 
of zinc in the food. If zinc was administered in the form of liquid solution to 
fasting individuals, it will be absorbed more (60-70%). Very less amount of zinc 
will be adsorbed from the solid diets. 
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Accepted average zinc absorption is 33%. Zinc absorption rate varies in 
different population groups due to different types of dietary practices and 
phytate: zinc molar ratio. Zinc status plays an important role in zinc absorption. 
Those individuals, whose diet contains less zinc, will absorb zinc more 
efficiently. Whereas individuals zinc rich diet show reduced efficiency of 
absorption. 
During digestion, zinc is released as free ions from the food. Before their 
transport into enterocytes in the duodenum and jejunum, these free ions will 
bind to ligands (secreted endogenously). Afterwards free ions attached to 
various transport proteins which leads to passage of zinc into portal circulation. 
If zinc was taken in higher amounts, some part of it will be absorbed through 
passive para cellular route.  
Through portal circulation, absorbed zinc reaches liver. From the liver 
zinc is released into systemic circulation. From systemic circulation zinc is 
released to various tissues. In systemic circulation, 70% of zinc is attached to 
albumin. If any reduce in serum albumin levels will have effect on zinc levels in 
the serum. 
Zinc transporters (ZnTs)[34] 
There are minimum 10 zinc transporters and 15 zip transporters and 3 
forms of metallothionein in human cells. These transporters appear to have 
contrasting roles in zinc homeostasis at cellular level. Zinc transporters were 
regulated by changes in zinc level[6].Zinc Transporterslowersthe availability of 
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zinc in intracellular level by enhancing efflux of zinc from cells into 
intracellular vesicles whereas, zip transporters increase the availability of  zinc 
in intracellular level by enhancing extracellular zinc uptake and vesicular zinc 
release into the cytoplasm.Both will exhibit tissuespecific expression, varied 
responsiveness to dietary zinc deficiency/ excess.[34] 
Figure 13: Active zinc transport across the cell membrane
 
 These gradients are produced by 2 mechanisms. (1) primary pump by using the 
energy of ATP- hydrolysis, (2) Na+/ Zn2+exchanger.[37] 
(1) Primary pump 
In some studies they proposed that ATPase pump actively 
transports across cell membrane. But still there is no evidence has 
been found in mammalian or human cells. 
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(2)  Na+/ Zn2+exchanger ( 3Na+/ 1Zn2+) 
It is a member of Na+/ Ca2+exchanger super family which promotes 
efflux of Zn2+against 500 fold transmembrane gradient. 
Zinc homeostasis: 
Primary mechanisms for maintaining Zinc homeostasis are changes in the 
absorption and excretion of zinc in the gastro intestinal tract and renal 
regulation   
1) Gastro intestinal regulation: 
It is the key site for regulation of homeostasis.In this, mechanism will be 
changes in excretion into the faeces and absorption of zinc. According to 
Jackson et al. (1984), with increase in intake of zinc, excretion of zinc 
increased. Absorption of zinc will respond more slowly to increase in intake of 
zinc.[38] 
 
2) Changes in faecal excretion of zinc: 
It is made up of 2 components (1) obligatory / metabolic loss, (2) 
endogenous loss (Weigand and Kirchgessner 1980). According to Baer and 
King 1984, obligatory faecal excretion of zinc was estimated from quantity 
of zinc excreted (approx. 6-8µmol/d). If intake of zinc reduced, efficiency of 
zinc absorption increased. If absorption of zinc reduced, faecal excretion of 
zinc also reduced.[38] 
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3) Renal regulation: 
  Renal loss of zinc will be low when compared with gastro 
intestinal losses. When intake of zinc is very low, urinary zinc extretion will be 
decreased. 
 
4) Other sources of loss of zinc[38]: 
a. Insensible losses (sweat and other surface losses) 
b. Seminal emissions (approx. 9µmol per ejaculum) 
c. Menstrual losses 
d. Hair and nail growth (approx. 0.5µmol zinc loss/day) 
 
Zinc is present in all body tissues with majority is present in bone and muscle 
(Figure 14). 
 
If intake of zinc was very low or only small amounts of zinc taken for long 
periods, homeostatic changes may not be adequate to replace losses. With 
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severe deficiency of zinc, whole body content reduced. But loss will not be 
constant throughout the body. In skin, heart, hair and muscle, zinc 
concentrations were almost normal. In testes, liver, bone and Plasma, zinc 
concentrations were decreased significantly[38]. 
 During catabolic phase, zinc is released and taken up by various 
tissues.During this phase, zinc was liberated by bone and taken up by muscle 
tissue. In severe Zn deficiency, increased retaining of zinc in specific tissues 
leads to pronounced drop in internal losses of zinc[38].  
With very low intakes of zinc, primary homeostatic mechanisms become 
inactive which leads to activation of secondary mechanisms. These includes 
decrease in excretion of zinc in urine, rise in fractional turnover rates, increased 
retaining of zinc in specific tissues such as muscle to maintain homeostasis[38]. 
Dietary components effecting zinc absorption 
 Zinc absorption from water solutions was considerably high when 
compared to zinc absorption from meals. Zinc bioavailability also depends on 
type of protein. Animal proteins curb the inhibition of zinc absorption by 
phytates. This effect is due to release of amino acids from proteins. According 
to sandstorm et al, absorption of zinc was lower in cow’s milk than infant 
formula which is whey based. Because whey based milk has positive effect on 
absorption of zinc when compared to casein[39]. 
Staple foods like corn, cereals, legumes, rice contains phytates which 
have negative effect on absorption of zinc. Phytate composed of different types 
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of inositol phosphate like hexa phosphates, triphosphates penta phosphates and 
tetra phosphates. Out of which pentaphosphate and hexaphosphate have 
negative effect on absorption of zinc[39]. 
The amount of calcium in the meal will have negative effect on zinc 
absorption as calcium tends to form complexes with zinc and phytate. Organic 
acids like lactic, malic and citric acid will increase absorption of zinc[39]. 
Figure 15: Dietary requirements of zinc[40] 
 
Functions of zinc: 
Cell level functions can be of 3 categories: 
Structural:  
It has a principal role in cell membrane and proteins structure. So 
deficiency of zinc leads to increase in susceptibility of cell membranes to 
oxidant induced damage. 
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Regulatory:  
Zinc proteins acts as transcription factors which controls the expression 
of gene. Zinc helps in release of hormones and nerve impulse propagation by 
sending signals to the cells. 
Catalytical: 
 Zinc plays a pivotal role as a catalyst in over 100 enzyme mediated 
reactions[41].  
Zinc deficiency 
Epidemiology  
World: 
It plays a considerable role in global anemia burden. In countries where 
populations taking very low quantities of animal sources and plant sources with 
excessive inhibitors like phytates are at potential risk of deficiency. According 
to world health organisation (WHO) estimates, 1/3rd of the world population 
(approx. 2 billion people) have deficiency of zinc. Deficiency of zinc found out 
to be important risk factor for pneumonia and diarrhea which contributes to 
20% perinatal mortality rate throughout the world. Zinc is a risk factor in 18% 
of malarial cases, 16% of LRTIs, 10% of diarrheal cases throughout the 
world[42].  
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High risk groups: 
1) Infants and children:  
 Due to rise in requirements for growth, this group is at higher risk 
of developing deficiency of zinc. Infants who are fed only with breast 
milk will have adequate requirements up to 6months of life. After that 
infants started on weaning which should contain adequate quantity of zinc 
to maintain whole body zinc. Deficiency of zinc in poor countries is due 
to delay in starting of weaning or cereals with low quantity of zinc.  
 In low birth weight babies, there will be very low stores of zinc in 
the liver. In preterm infants, zinc levels still reduced as zinc will be 
transferred in later part of pregnancy. Due to immature GIT, Premature 
babies will have decreased absorption. Requirements of zinc in 
undernourished children will be higher than normal children. 
2) Adolescents:  
During puberty, physiological zinc requirements will be higher 
when compared to other groups. 
3) Pregnant and lactating woman: 
Due to increased caloric requirement, this group tends to develop 
deficiency of zinc. During lactation, requirement of zinc is even higher[7]. 
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4) Elderly:  
Intake of zinc in old people is low according to various diet 
surveys. Absorption of zinc will be decreased with increase in age[34]. 
Figure 16: Causes of deficiency of zinc[43] 
 
Figure 17: Symptoms of deficiency of zinc[43] 
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Deficiency of zinc divided into mild, moderate and severe. In mild 
deficiency, features like decreased taste sensation, decreased count of sperms, 
low testosterone levels, loss of weight. In moderate deficiency which is 
generally associated with malnutrition and chronic diseases, usually presents as 
growth retardation, late development of gonads, abnormalities of skin, poor 
appetite, excessive sleepiness, decreased adaptation in dark environment, late 
healing of wounds. In severe deficiency, it is presented with 
acrodermatitisenteropathica, pustular / bullous dermatitis, diarrhea, mental 
depression, alopecia. Deficiency of zinc also causes repeated infections[43]. 
Role of zinc in various diseases: 
Diarrhea: 
Zinc is important micronutrient which prevents damage by oxidants. As 
loss of zinc through diarrhea, deficiency of zinc is usually associated it. Hence 
supplementation of zinc became important mode of intervention in management 
of diarrheal disease. Many studies showed beneficial effects of zinc in diarrheal 
disease and its role in prevention[7,44].  
Out of these studies, many studies were done in Asian countries. In these 
countries, deficiency of zinc is common. According to combined data from 
various randomized controlled trials on role of zinc in diarrhea, those who 
received supplements of zinc showed 15% reduced likelihood of persistence of 
diarrhea when compared with control group. In persistent diarrhea patients, 
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there will be 24% reduced likelihood of continuing diarrhea. If given 
supplements of zinc, there will be lower failure of treatment and death[7]. 
According to Bhatnagar S et al, those children who were supplemented 
with zinc, output of stools decreased by 31% than in control (placebo) group. 
These findings will not vary with nutrient status or age. Effect of zinc on 
diarrhea will not vary depending on the type of salt used[7].   
 
Pneumonia: 
Pneumonia is important cause of mortality all over the world. Zinc has 
important role in immunity. According to Bhandari N et al, supplementation of 
zinc found to have 26% reduction in pneumonia [45]. According to brooks et al, 
supplementation of zinc 30% decrease in period of severe respiratory infection 
and there was 25% average reduced stay in the hospital[46].   
 
Malaria: 
According to Shankar AH et al, supplementation of zinc observed to 
decrease visits to hospitals for malaria. According to Vmuller et al, there will 
not be significant effect of supplementation of zinc on malaria. According to 
zinc against plasmodium group, there is no significant effect on malaria even 
after improvement in zinc levels by supplementation of zinc[47–49].  
 Role of zinc on mortality: 
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 According to Baqui AH et al, children who received supplementation of 
zinc reduced duration of diarrhea and incidence when compared with controlled 
group. There is also reduced admission to hospital and mortality due to 
diarrhea[50].   
 According to Sazawal S et al, supplementation of zinc in low birth weight 
babies leads to 68% decrease in death. These babies were supplemented with 
5mg of zinc daily from1month of age to 9months of age[51]. 
Role of zinc on growth and development[52]: 
 Zinc was involved in metabolism of bone. Hence zinc has very crucial 
role in development. Zinc also important part bone matrix. Through its positive 
effect on synthesis of DNA, it increases the effect of vitamin D. 
Maternal deficiency of zinc leads to various effects on the baby. 
Figure 18: 
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Supplementation of zinc will reduce loss of appetite which in turn beneficial for 
growth. Zinc activates insulin like growth factor which in turn helps in growth 
of the individual[52]. 
Role of zinc in brain and behavioural function: 
Zinc plays important role in CNS development. Deficiency of zinc can 
result in restriction in development of intellectual functions. Various enzymes 
which are dependent on zinc helps in growth of the brain. Zinc proteins take 
part in neurotransmission and structure of brain. Various neuro transmitters 
which are dependent on zinc take part in functions like memory. Zinc also took 
part in manufacturing of precursor neurotransmitters[52] 
Role of zinc in febrile seizures: 
 In brain, zinc is present in large quantities in the hippocampus (approx. 
30µg/g weight). Zinc regulates glutamic acid decarboxylase activity which is an 
important enzyme in production of γ- amino butyric acid. It also regulates the 
neurotransmitter affinity. It mediates inhibition of calcium on N-methyl-D-
aspartate receptors there by reducing excitatory discharge of neurons. In 
deficiency of zinc, these receptors get stimulated which may produce 
epileptiform discharges in children with fever[5]. 
According to Ganesh et al, zinc levels in febrile seizures children were 
lesser than febrile children. This indicates that zinc deficiency may be a 
important factor in febrile seizures pathogenesis[5]. Zinc also activates 
pyridoxal kinase, which in turn helps in the pyrioxal phosphate synthesis from 
52 
 
pyridoxal. Pyridoxal phosphate inturn activates glutamic acid decarboxylase 
which involved in synthesis of GABA. Post synaptic receptors in interaction 
with zinc assists in GABA action. Hence hypozincemia leads to decrease in 
GABA level which leads to development of seizures. According to Ehsanipour 
et al, zinc levels will be low in febrile seizures and during infection. But zinc 
levels were significantly low in patients with febrile seizures[53]. 
Diagnosis: 
Deficiency of zinc can be estimated by measurement of zinc levels in 
serum by various methods. But atomic absorption spectrophotometer is most 
accurate method to estimate zinc levels. Confirmation of zinc deficiency can be 
done by zinc challenge are most accurate method[43]. 
Table 1: zinc levels 
  Zinc level in serum (µg/dL) Condition  
300 – 700 Acute zinc toxicity 
160-299 Due to increased intake 
84-159 Normal  
60-83 Deficiency, fluctuations in zinc levels 
< 59 Deficiency  
<30 Definite deficiency 
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There may be variations in serum zinc levels depending on time of drawing 
blood and drugs etc[43]. 
Figure 19: 
 
Toxicity of zinc: 
Excessive intake of zinc ranging from 150mg/day to 1-2 gm/day may 
cause toxicity of zinc. Toxicity will cause various deleterious effects on human 
body. Toxicity of zinc can be acute, sub chronic or sub chronic[36].  
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Table 2: Acute toxicity of zinc[36] 
 
Chronic toxicity of zinc[36]: 
Zinc exposure for long periods leads to deficiency of copper. It also leads 
to hypoferremia and low haematocrit. It also has effects on various systems. 
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Treatment of deficiency of zinc: 
Zinc will be supplemented for the treatment of zinc deficiency. The dose 
in children less than 6months will be 10mg/day and > 6months will be 
20mg/day. This therapy should be continued for a period of 4 months. If therapy 
started with in 6months of deficiency, success rate of treatment is high[43].  
 
Iron: 
 One of the important and widely prevalent nutritional problems 
throughout the world is deficiency of Iron. Along with developing countries, 
deficiency of Iron is widely prevalent in developed countries. 
 In developing countries, almost all children of pre-school age, and 
pregnant ladies had deficiency of Iron. In developed countries 30-40% of the 
preschool children and pregnant ladies had deficiency of Iron. In South Asia, 
anaemia is more prevalent than other parts of the world. In India, prevalence for 
pregnant and non-pregnant women was 88% and 74% respectively. Prevalence 
for preschool children in India was almost similar[54,55]. 
  
  
Figure 20: 
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Sources of heme Iron[56] 
 
 Figure 21: 
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Sources of non-haem iron 
 
 
 Figure 22: Vitamin C sources to increase Iron absorption
Figure 23 :Prevalence of a
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naemia based on concentration of haemoglobin
 
 
[54]: 
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Epidemiology[54,56]: 
Prevalence depends on various host factors. They are 1) age, 2) sex, 3) 
environmental, 4) physiological, 5) pathological, and 6) socio economic status. 
These factors influence dietary intake which in turn leads to deficiency.  
1) Age: (ida assessment prevention control) 
In term infants, adequate stores of iron in liver and haematpoietic 
tissues are present. low levels of iron are present in breast milk ,so 
we have to compliment the food which can absorb more iron. 
Figure 24: 
 
2) Sex:After attaining menarche adolescents do not take sufficient amount 
of iron during their menstrual cycles. So, peak incidence is seen in 
adolescent females.           
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3) Environmental: 
Folic acid, vitamins A, B 12, C and copper etc. may also necessary for 
haematopoiesis along with iron may also be deficient. Any trauma or any 
chronic systemic illness in the childhood may cause iron deficiency. 
4&5)Physiological &Pathological: 
6) Socio-economic status: Common in below poverty line population.  
Iron metabolism: 
 Figure 25: Below diagram showing absorption and metabolism of Iron in 
the gut. 
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Figure Hemoglobin production and catabolism: 
 
Role of Iron deficiency in febrile seizures: 
Iron is an important element for metabolism in the brain. It also helps in 
neuro transmitter metabolism. Deficiency of iron acts as an important factor in 
development of febrile seizures. Iron deficiency is one of most common 
nutritional problem around the world. Kumari et al. conducted a case control 
study involving large sample size. They reported that deficiency of iron was 
seen in majority of the patients. They concluded that, deficiency of iron is one 
of the important factors in development of febrile convulsions[6]. According to 
a study conducted in Kenya, deficiency of iron is not a risk factor for other 
acute convulsions. But it acts as important factor in febrile convulsions[57]. 
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Signs&Symptoms[54,56,58]: 
Symptoms of iron deficiency can be very mild at first,and completely un 
noticed. 
• General fatigue 
• Weakness 
• Pale skin 
• Shortness of breath 
• Dizziness 
• Pica 
• Tingling/crawling  feeling in the legs 
• Swelling /soreness in the tongue 
• Cold hands & feet 
• Fast/irregular heart beat 
• Brittle nails 
• Headaches 
• Hair loss 
• Twitches 
• Restless legs syndrome 
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Approach to iron deficiency anaemia[58]:  (Figure 27) 
 
How to differentiate from other microcytic anaemia? (Figure 28) 
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Indicators of Iron deficiency Anaemia[58]: (Figure 29): 
 
Differential diagnosis of iron deficiency: 
1) Thalassemia 
2) Haemoglobin C and E disorders 
3) Anaemia of chronic disease 
4) Lead poisoning 
5) Sickle cell anemia 
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Management of Iron deficiency[56,58]: 
Deficiency of Iron can be treated by supplementation of elemental iron. 
Iron can be given in 2 types of preparations 
1. Oral iron preparation 
2. Parenteral iron preparation 
Oral iron therapy: 
 Dose should be calculated for elemental iron. 3-6mg/kg/day in 3 divided 
doses can be given. Common forms used are ferrous sulphate which contains 
elemental iron of 20%. It should be given in meals along with juice to increase 
compliance.  
Side effects of oral Iron preparations: 
Gastro intestinal disturbances such as epigastric pain, irregular bowel 
habits etc. Proton pump inhibitors may also decrease the absorption of iron 
Response to iron therapy: (Figure 30) 
 
Parenteral Iron therapy[54]:  
parenteral therapy is indicated in the presence of malabsorption or who 
are not responsive to Iron therapy. Various parenteral Iron preparations are 
available. 
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RESULTS 
Study population included 100 patients divided into two groups. Two 
groups included 50 cases (febrile seizures) and 50 controls (febrile children 
without seizures) that came to out-patient department or admitted as in-patient. 
Table 3 describes about characteristics of both groups. Age, Nutritional status 
were matched in both groups.  
Table 3: Characteristics of patients in both groups 
 febrile seizures 
(n=50) 
Fever without 
seizures 
(n=50) 
p-value 
Sex (male:female) 
Male  
female 
1.17:1 
27 
23 
 
33 
17 
 
>0.05 
Mean age(in months) 22.62 ± 12.45   23.14 ± 15.58 >0.05 
Nutritional status 
Normal  
Grade I malnutrition 
Grade II malnutrition 
Grade III malnutrition 
Grade IV malnutrition 
 
40 
10 
Nil 
Nil  
Nil 
 
40 
10 
Nil 
Nil 
Nil 
 
 
1.00 
Family history of 
febrile seizures 
11 0 0.002 
Mean temperature 101.61 ± 1.31  101.17 ± 0.86 >0.05 
Socio economic status 
Upper 
Upper middle 
Middle 
Upper lower 
Lower  
 
 
1 
9 
5 
11 
24 
 
1 
6 
7 
15 
21 
 
 
 
0.782 
Duration of seizure 
<5mins 
5-10mins 
10-15mins 
 
40 
10 
0 
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In the study population, 70% of the cases (35/50) had acute respiratory 
infection, 14% of the cases (7/50) each had AGE and Viral fever. 2% of the 
cases had UTI (1/50). 54% of the controls (27/50) had ARI. 24% of the controls 
(12/50) had viral fever. 20% of the controls (10/50) had AGE. 2% of the 
controls had UTI (1/50)   (Table 4, Figure 31 &32). 
 
Table 4: Diagnosis in cases and controls 
 Cases (n=50) Controls (n=50) 
Diagnosis  Number of patients Percentage  Number of patients  Percentage  
ARI                                35              70%                                  27                         54% 
AGE                                  7              14%                                  10                         20% 
VIRAL FEVER                                  7              14%                                  12                         24% 
UTI                                  1                  2%                                    1                           2% 
TOTAL                                50             100%                                  50                        100% 
     
 
Figure 31: 
 
 ARI is the predominant diagnosis followed by acute gastroenteritis (14%), viral 
fever (14%) and UTI (2%) respectively. (Table 4and figure 31). 
70%
14% 14% 2%
0%
20%
40%
60%
80%
ARI AGE VIRAL FEVER UTI
Diagnosis in cases
Diagnosis
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Figure 32: 
 
 
ARI is the predominant diagnosis in controls (54%) followed by viral fever 
(24%), AGE (20%) and UTI (2%) respectively. (Table 4 and figure 32) 
 
TABLE 5: Age distribution of cases and controls 
 Cases (n=50) Controls (n=50) 
AGE 
GROUP(months) 
NO. OF PATIENTS PERCENTAGE NO. OF 
PATIENTS  
PERCENTAGE 
≤ 24 MONTHS 37                 74% 33 66% 
>24 MONTHS                      13                 26% 17 34% 
TOTAL                      50              100%      50 100% 
 
 
 
 
54%
20%
24%
2%
0%
10%
20%
30%
40%
50%
60%
ARI AGE VIRAL FEVER UTI
Diagnosis in controls
 74% of the cases (37) belong to 
belong to >24months age group.
66% of the controls (33) belong to 
controls (17) belong to >24months age group. (Table 5
 
26%
69 
Figure 33: 
≤24months age group and 26% of the cases (13) 
 (Table 5 and figure 33) 
Figure 34: 
≤24months age group and 34% of the 
 and figure 
74%
No of Cases
66%
34%
No. of Controls
≤
> 24 months
 
 
34) 
≤ 24 months
>24 months
 24 months
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TABLE 6: 
 
 CASES (n=50) CONTROLS (n=50)  
MEAN 22.62 23.14 
STANDARD DEVIATION 12.45 15.58 
 
 
Figure 35: 
 
 
Mean age in cases and controls were 22.62 ± 12.45 and 23.14 ± 15.58 months 
respectively. The difference was not statistically significant (p-value is >0.05). 
(Table 6 and figure 35).  
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 Table 7: Gender distribution of cases and controls
 
GENDER NO.OF PATIENTS
MALE 27 
FEMALE 23 
TOTAL 50 
Figure 
 
54% of the cases were male (27) and 46% of the cases were female (23). Male: 
female ratio was 1.17:1. (
 
46%
71 
 
CASES (n=50) CONTROLS (n=50)
 PERCENTAGE NO.OF PATIENTS
54% 33 
46% 17 
100% 50 
 
36: Gender distribution of cases 
Table 7 and figure 36) 
 
54%
NO.OF PATIENTS
 
 
 PERCENTAGE 
66% 
34% 
100% 
 
MALE
FEMALE
 Figure 
 
66% of the controls (33) were male and 34% of 
There is no statistical difference between two groups (p
and figure 37) 
TABLE 8: Temperature in cases and controls
 
MEAN 
STANDARD DEVIATION 
 
 
34%
72 
37: Gender distribution of controls 
the controls (17) were
- value >0.05). (
 
CASES (n=50) CONTROLS (n=50)
101.61 101.17 
1.31 0.86 
 
66%
NO.OF PATIENTS
 
 female. 
Table 7 
 
MALE
FEMALE
73 
 
Figure 38: 
 
Mean temperature in cases and controls were 101.61 ± 1.31°F and 101.17 ± 
0.86°F respectively. The difference between two groups was not statistically 
significant (p-value >0.05). (Table 8 and figure 38) 
 
Table 9: Family History of Febrile Seizure 
 
 CASES (n=50) CONTROLS (n=50) 
FAMILY H/O FEBRILE 
SEIZURE 
NO.OF 
PATIENTS 
PERCENTAGE NO. OF PATIENTS PERCENTAGE 
PRESENT  11  22%  0  0% 
ABSENT  39  78% 50 100% 
TOTAL  50 100% 50 100% 
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 Figure 39: family history of febrile seizures
 
ACTUAL VALUES 
FAMILY H/O FEBRILE SEIZURES 
PRESENT 
ABSENT 
TOTAL 
 
 
EXPECTED VALUES 
FAMILY H/O FEBRILE SEIZURES 
PRESENT 
ABSENT 
TOTAL 
 
 
 
78%
74 
 
Table 10: 
   
CASE CONTROL TOTAL PATIENTS
11 0 11 
39 50 89 
50 50 100
Table 11: 
   
CASE CONTROL TOTAL PATIENTS
5.5 5.5 11 
44.5 44.5 89 
50 50 100
22%
family history
 
 
 
 
 
PRESENT
ABSENT
75 
 
Table 12: 
Chi Test p-value 0.002 
Chosen significance value 0.05 
 
22% of cases (11/50) had family history of febrile seizures. In controls there 
was no family history of febrile seizures. The difference between two groups 
was statistically significant (p-value 0.002). (Table 9,10,11,12 & figure 39) 
 
Table 13: Socio economic status 
 
 Cases (n=50) Controls (n=50) 
SOCIO ECONOMIC STATUS No.of 
patients 
Percentage  No. of patients  Percentage  
UPPER               1            2%                               1 2% 
UPPER MIDDLE              9                          18%                               6 12%  
MIDDLE/LOWER MIDDLE              5                         10%                               7 14% 
LOWER/UPPER LOWER             11                           22%                             15  30% 
LOWER             24                           48%                            21 42% 
TOTAL              50                        100%                             50                        100% 
 
  
  
 
 
 
48%
SOCIO ECONOMIC STATUS IN CASES
42%
SOCIO ECONOMIC STATUS IN CONTROLS
76 
Figure 40: 
Figure 41: 
2%
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UPPER
UPPER MIDDLE
MIDDLE/LOWER MIDDLE
LOWER/UPPER LOWER
LOWER
2%
12%
14%
30%
UPPER
UPPER MIDDLE
MIDDLE/LOWER MIDDLE
LOWE/UPPER LOWER
LOWER
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Table 14: 
ACTUAL VALUES    
SOCIOECONOMIC STATUS CASE CONTROL TOTAL PATIENTS 
UPPER 1 1 2 
UPPER MIDDLE 9 6 15 
MIDDLE/LOWER MIDDLE 5 7 12 
LOWER/UPPER LOWER 11 15 26 
LOWER 24 21 45 
TOTAL 50 50 100 
 
Table 15: 
EXPECTED  VALUES    
SOCIOECONOMIC STATUS CASE CONTROL TOTAL PATIENTS 
UPPER 1 1 2 
UPPER MIDDLE 7.5 7.5 15 
MIDDLE/LOWER MIDDLE 6 6 12 
LOWER/UPPER LOWER 13 13 26 
LOWER 22.5 22.5 45 
TOTAL 50 50 100 
 
Table 16: 
Chi Test p-value 0.782 
Chosen significance value 0.05 
 
Lower socio economic status group was the predominant group (48%) in cases 
followed by upper lower (22%), upper middle (18%), lower middle (10%) and 
upper (2%) respectively. In controls, Lower socio economic group was the 
predominant group (42%) followed by upper lower (30%), lower middle (14%), 
upper middle (12%) and upper (2%) respectively. The difference between both 
groups was not significant (p-value 0.782). (Table 13,14,15,16 & figure 40, 41) 
  
NUTRITIONAL STATUS 
NORMAL 
GRADE (I) 
GRADE (II) 
GRADE (III) 
GRADE (IV) 
TOTAL 
 
 
 
 
20%
NUTRITIONAL STATUS IN CASES
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Table 17: Nutritional status 
Cases (n=50) Controls
No.of 
patients 
Percentage  No. of patients  
             40             80%                             40
            10                   20%                             10
              0                     0%                               0
              0                     0%                               0 
              0                     0%                              0
             50                100%                             50  
Figure 42: 
 
80%
 (n=50) 
Percentage  
 80% 
 20%  
   0% 
   0% 
   0% 
                      100% 
 
NORMAL
GRADE (I)
 80% of the cases (40) had normal nutritional status and 20
had grade-I malnutrition. 
and 20% (10) had grade-
not statistically significant (p
Table 18: Mean values of all investigations in cases and 
 
 
Investigations Mean  
Sr. Iron 51.4 
Haemoglobin  10.6 
MCV 68.7 
MCHC 33.1 
MCH 22.8 
RDW 16.1 
Sr. Zinc   49.8 
 
 
NUTRITIONAL STATUS IN CONTROLS
79 
Figure 43: 
% of the cases (10) 
In controls, 80% (40) had normal nutritional status 
1 malnutrition. The difference between two groups is 
-value 1.000). (Table 17, figure 42&43)
Cases  Controls 
Standard 
deviation 
Mean  Standard 
deviation
37.0 82.3 18.6 
0.9 11.6 0.8 
6.3 76.5 6.5 
1.4 33.6 1.1 
2.4 26 2.6 
1.6 14.3 1.5 
38.6 92.2 33.5 
80%
20%
 
 
controls 
 
 
p- value 
<0.0001 
<0.0001 
<0.0001 
  0.0629 
<0.0001 
<0.0001 
<0.0001 
NORMAL
GRADE (I)
80 
 
Figure 44: Mean serum zinc levels in cases and controls
 
Mean serum Zinc levels in cases and controls were 49.8 ± 38.6 and 92.2 ±33.5 
μg /dl respectively. Mean zinc levels were low in cases. With t = 5.8539 and 
with 95% confidence interval, p-value is < 0.0001. It was strongly significant. 
Lowest Zinc level was 14 μg /dL. Highest Zinc level was 126μg/dL. (Table 18 
& figure 44) 
Figure 45: Mean serum iron levels in cases and controls 
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Mean serum iron levels in cases and controls were 51.4 ± 37 and 82.3 ± 18.6μg 
/dl.Mean serum iron levels were low in cases than controls. With t = 5.2719, 
and 95% confidence interval, p value is <0.0001. It was statistically significant. 
Lowest iron level was 13µg/dL and highest Iron level was 67.4 in cases. (Table 
18 & figure 45) 
Figure 46: Mean haemoglobin in cases and controls: 
 
Mean Haemoglobin levels in cases and controls were 10.6 ± 0.9 and 11.6 ± 0.8 
gm/dl respectively. With t = 5.74,and with 95% confidence interval, p- value is 
<0.0001, it was strongly significant. Lowest haemoglobin level was 8.6g/dL. 
Highest haemoglobin level was 12.2g/dL. (Table 18& figure 46) 
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Figure 47: Mean MCV levels in cases and controls 
 
 
Mean MCV levels in cases and controls were 68.7 ± 6.3 and 76.5 ± 6.5 
flrespectively. With t = 6.062, and with 95% confidence interval, p-value is 
<0.0001. It was strongly significant. Lowest MCV value was 52.8 and highest 
MCV value was 82.8 fl. (Table 18& figure 47) 
Figure 48: Mean MCHC levels in cases and controls 
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Mean MCHC levels in cases and controls were 33.1 ± 1.4 and 33.6 ± 1.1 % 
respectively. There was no significant difference between 2 groups (P-value is 
0.0629). Highest MCHC value was 34.6 % and lowest MCHC value was 30.4 
%. (Table 18& figure 48) 
 
Figure 49: Mean MCH levels in cases and controls 
 
 
 
Mean MCH levels in cases and controls were 22.8 ± 2.4 and 26 ± 2.6pg 
respectively. With t = 6.4332, and with 95% confidence interval, p-value is 
<0.0001. It was strongly significant. Lowest MCH value was 18.2pg and 
highest MCH value was 24.6pg. (Table 18 & figure 49). 
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Figure 50: Mean RDW levels in cases and controls 
 
 
Mean RDW values in cases and controls were 16.1 ± 1.6 and 14.3 ± 1.5 % 
respectively. With t = 6.321, and with 95% confidence interval, p value is 
<0.0001. It was strongly significant. Highest RDW value was 20.8%. Lowest 
RDW value was 15.1%. (Table 18& figure 50) 
Table 19: Mean values of all investigations in <24 months age group: 
 Cases  Controls  
Investigations Mean  Standard 
deviation 
Mean  Standard 
deviation 
p- value 
Sr. Iron 47.09 33.3 80.6 21.07 <0.0001 
Haemoglobin  10.4 0.7 11.5 0.8 <0.0001 
MCV 68.11 5.5 74.5 6.7 <0.0001 
MCHC 32.9 1.4 33.4 1.1   0.098 
MCH 22.6 2.3 25.3 2.7 <0.0001 
RDW 16.3 1.6 14.6 1.68 <0.0001 
Sr. Zinc   49.8 38.6 92.2 33.5 <0.0001 
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Table 20: Mean values of all investigations in >24 months age group 
 Cases  Controls  
Investigations Mean  Standard 
deviation 
Mean  Standard 
deviation 
p- value 
Sr. Iron 63.5 45.05 85.3 12.57   0.067 
Haemoglobin  11 1.32 11.8 0.58   0.032 
MCV 70.2 8.2 80.2 4.2 <0.0001 
MCHC 33.5 1.4 33.7 1.1   0.544 
MCH 23.3 2.5 27.3 1.4 <0.0001 
RDW 15.4 1.5 13.6 0.65 <0.0001 
Sr. Zinc   49.6 42.1 99.7 35.7 <0.001 
 
Table 19 and 20 showed that mean levels of serum iron and other red cell 
indices were comparatively lower in <24 months age group than >24 months 
age group. In >24 months age group, mean values of haemoglobin, MCHC, iron 
were not statistically significant. In both <24 months and >24 months age 
group, mean serum zinc levels were significantly lower (p-value: <0.0001 and 
<0.001 respectively) 
Table 21: Duration of seizure 
Duration of seizure No of patients Percentage 
<5mins 40 80% 
5-10mins 10 20% 
>10mins 0 0% 
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Figure 51: 
 
Table 21 and figure 51 showed that duration of seizure was < 5minutes in 80% 
of cases (40/50) and >5mins in 20% of the cases (10/50). 
Figure 52: Comparison of mean levels between <5minutes and 5-10 minutes 
group 
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Mean zinc levels were comparatively lower in 5-10 minutes group when 
compared with <5minutes group. Mean iron levels and red cell indices levels 
were lower in <5minutes group when compared with 5-10 minutes group. There 
was no significant difference between two groups (p-value > 0.0001). (Figure 
52) 
Table 22: Odds ratios 
 
 Cases  Controls  Total   
 
 
Only low 
Iron           
 
  Present  
      %                    
6 
60% 
4 
40% 
10 
100% 
Odds ratio: 1.568 
Relative risk: 1.227 
p- value: 0.507 
 Absent  
      % 
44 
48.9% 
46 
51.1% 
90 
100% 
Total     Count  
      % 
50 
50% 
50 
50% 
100 
100% 
 
 
 
 Cases  Controls  Total   
 
 
Only low 
zinc           
 
  Present  
      %                    
4 
36.4% 
7 
63.6% 
11 
100% 
Odds ratio: 0.534 
Relative risk: 0.704 
p- value: 0.343 
 Absent  
      % 
46 
51.7% 
43 
48.3% 
89 
100% 
Total     Count  
      % 
50 
50% 
50 
50% 
100 
100% 
 
 
 Cases  Controls  Total   
 
 
Both low 
zinc and 
iron          
 
  Present  
      %                    
37 
94.9% 
2 
5.1% 
39 
100% 
Odds ratio: 68.30 
Relative risk: 4.45 
p- value: <0.0001 
 Absent  
      % 
13 
21.3% 
48 
78.7% 
61 
100% 
Total     Count  
      % 
50 
50% 
50 
50% 
100 
100% 
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In the study population, if they were having both low levels of Iron and Zinc, 
they 68.3 times more risk for developing febrile seizures with p-value <0.0001. 
Relative risk is 4.45. if they were having only low levels of zinc or iron,  the 
relative risk is 0.704 and 1.227. Both were not significant. 
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DISCUSSION 
Febrile convulsions are one of the common paediatric emergencies 
encountered around the world. Febrile seizures occur in 6 months to 5 years of 
age[4,31]. Incidence of febrile convulsions around the world is between 3-4%.  
It is of similar incidence all over the world. At least 3-4 % children may have 
one episode below 5years of age. In India, incidence is almost 10% according to 
some studies. But recent studies indicate that incidence is almost comparable to 
western population[3]. In febrile children, some may develop febrile 
convulsions and some may not develop febrile convulsions. The underlying 
mechanism is still not clear. Various mechanisms like genetic factors, family 
history of febrile convulsions, deficiency of Iron and zinc were proposed[59]. 
Various studies showed that deficiency of Iron and zinc as risk factors for 
development of convulsions. In this study, we hypothesised that Low Zinc and 
Iron levels may lead to development of febrile convulsions. 
1) Mean age in months:  
In the present study mean age was 22.62 ± 12.45 months. There 
was no statistical difference between two groups (p-value >0.05). A study 
conducted at Chennai by Ganesh et al showed a mean age of 23.8 
months[5]. Mahyar et al conducted a case control study in 2006 involving 
52 febrile convulsion children and 52 normal healthy controls. This study 
showed a mean age of 27.13 ± 15.72 months[60]. Another study done in 
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2009 by Farah et al, showed mean age of 21.25± 11.53[61]. Another 
study done in Pakistan by Waqar Rabbani et al showed mean age of 
23.97±14.45 months[59].Ihsankafadar et al conducted a study between 
august to November 2009. They found that median age in cases was 16 
months[62].  According to previous studies, 18 months is the median age 
of onset. In almost 50% of the children, onset is between 12-30 months of 
age[4]. 
2) Sex:  
In the study population, 54% (27/50) of the cases were male and 
46% (23/50) were female. Male: female ratio was 1.17:1. Males are 
predominantly had febrile seizures when compared with females. A study 
done by Farah et al showed that 40% of the cases were female and 60% 
of the cases were male[61]. According to Ganesh et al, there was no male 
predominance[5]. Another study conducted by conducted by Mahyar et al 
showed that 57.7% were male and 42.3% were female[60]. According to 
study conducted by Al- Zwaini et al male: female ratio reported to be 
between 1.1:1 to 4:1[10]. Waqar Rabbani et al conducted a case control 
study in Pakistan in 2011. They found that 66 out of 100 children were 
male (66%)[59]. According to a study conducted byJun-Hwa Lee et al in 
Korea showed that 115 of 248 cases were female (46.4%)[63]. 
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3) Aetiology of fever:  
In the study population, 70% (28/50 cases) had acute respiratory 
infection followed by Acute Gastroenteritis (14%) and viral fever (14%) 
respectively. According to a study conducted by Margareta et al in 2010, 
acute respiratory infection is the predominant diagnosis. Tomoum et al 
found that 60% of the cases were due to viral etiology[64].Waqar 
Rabbani et al found that upper respiratory tract infection is the 
predominant etiology (24%) followed by pneumonia (16%), urinary tract 
infection (16%) respectively[59]. Jun-Hwa Lee et al found that acute 
tonsillo pharyngitis is the predominant etiology followed by viral fever, 
bronchitis, pneumonia etc.[63]. 
4) Degree of temperature as a risk of seizures: 
It is clear that degree of rise of temperature may be a predisposing 
factor for development of seizures. Mean temperature in cases and 
controls were 101.61 ± 1.31° Fahrenheit and 101.17 ± 0.86°F in the 
present study. The difference between two groups was not statistically 
significant (p-value > 0.05). According to the study conducted by Ganesh 
et al, mean temperature in cases and controls were 102°F and 101.4°F 
respectively[5]. Margareta et al in 2009 found that mean temperature in 
cases and controls were 39.01± 0.56° C and 38.64 ± 0.45° C[64]. 
According to Jun-Hwa Lee et al, mean temperature in cases and controls 
were 38.3±0.9 °C and 36.5±0.3 ° C respectively. They found that it was 
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statistically significant[63]. Hassan et al conducted a case control study in 
Egypt found that mean temperature in cases and controls were 39±0.5 °C 
and 38.5±0.7° C respectively[65]. 
5) Family history of febrile seizures:  
Family history of febrile convulsions was seen in 22% of the cases 
(11/50 cases). There was no family history of febrile seizures in the 
control group in the present study. The difference between the two groups 
was statistically significant (p-value <0.001). A study conducted by 
Margareta et al showed that family history of febrile seizures is an 
important risk factor[64]. According to a study conducted by Sadleir et al, 
24% of febrile seizure children had family history[4]. According to 
karande et al done in India, 25-40% of febrile convulsion children had 
history of febrile convulsion in the family[3]. Hassan et al. studied 40 
cases of febrile seizures and 40 cases of febrile children in Egypt. They 
found that 87.5% (35/40 cases) had family history of febrile 
convulsion[65]. Ihsankafadar et al found that 44.4% had positive h/o 
febrile convulsions in the family[62]. 
6) Role of Zinc: 
In brain, zinc is present in large quantities in the hippocampus. 
Zinc regulates glutamic acid decarboxylase activity which is an important 
enzyme in production of γ- amino butyric acid. It also regulates the 
neurotransmitter affinity. It mediates inhibition of calcium on N-methyl-
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D-aspartate receptors there by reducing excitatory discharge of neurons. 
In deficiency of zinc, these receptors get stimulated which may produce 
epileptiform discharges in children with fever[5].  
Zinc also activates pyridoxal kinase, which in turn helps in the 
pyrioxal phosphate synthesis from pyridoxal. Pyridoxal phosphate inturn 
activates glutamic acid decarboxylase which involved in synthesis of 
GABA. Post synaptic receptors in interaction with zinc assists in GABA 
action. Hence hypozincemia leads to decrease in GABA level which 
leads to development of seizures[5].  
In the present study, mean serum zinc levels in cases and controls 
were 49.8 ± 38.6 and 92.2 ± 33.5 μg/dl respectively. The difference 
between the two groups was statistically significant (p-value <0.0001). 
Normal Zinc levels were ranging from 65-120μg/dl. Highest value 
was126µg/dl. Lowest value was 14µg/dl. A study done by Ganesh et al. 
showed that mean Zinc levels in cases and controls were 32.17 ± 15.05 
and 87.6 ± 17.6 μg/dl respectively[5]. According to Mahyar et al, mean 
zinc in cases and controls were 62.84 ±18.40 and85.70 ± 16.76 μg/dl 
respectively[60]. Waqar Rabbani et al found that low zinc levels may be a 
risk factor for development of febrile convulsions[59]. According to a 
study done by Hassan et al, median Zinc levels in cases and controls were 
53 and 93μg/dl respectively. A study conducted in Turkey by 
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Ihsankafadar et al found that there was no statistical difference of mean 
Zinc levels between cases and controls (110.49±35.03 µg/dL vs 
107.12±21.66 µg/dL)[62]. 
7) Role of iron: 
Iron is an important element for metabolism in the brain. It also 
helps in neuro transmitter metabolism. Deficiency of iron acts as an 
important factor in development of febrile seizures[6]. Deficiency of iron 
was diagnosed by combination of following parameters like haemoglobin 
<11gm/dl, MCV < 70 fl, MCHC <31%, MCH <23pg, Serum iron < 
65μg/dl, RDW >15%, serum ferritin <12ng/ml. 
 In the present study, mean Iron levels in cases and controls were 
51.4 ± 37.0 and 82.3 ± 18.6 μg/dl respectively. Lowest iron level in cases 
was13μg/dl. Highest level in cases was 67.4μg/dl.Thedifference between 
the two groups was statistically significant. A study done by Pisicane et al 
showed that mean serum iron in the cases were significantly lower than 
controls[6]. According to the study done by leelakumari et al, mean 
Serum iron was significantly lower[6]. According to Hassan et al , 
median serum iron level in cases and controls was 34 and 129μg/dl 
respectively[65]. Fallah et al conducted a study in Iran found that serum 
iron levels in cases and controls were 48.91 ± 22.96 and 75.13 ± 35.57 
μg/dl. According ghasem et al, mean iron level in cases and controls were 
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40.88±22.16 and 43.18±23.35μg/dl respectively. But the difference 
between two groups was not statistically significant[66]. 
In the present study, mean haemoglobin in cases and controls were 
10.6 ± 0.9 and 11.6 ± 0.8. Lowest haemoglobin value in cases was 
8.6gm/dl. Highest haemoglobin value was12.2gm/dl. The difference 
between the two groups were statistically significant (p-value <0.0001). 
Pisicane et al. found that mean haemoglobin was significantly lower 
when compared with controls. According to study done by Leelakumari 
et al, mean haemoglobin in cases and controls were 9.4±1.2 gm/dLand 
9.5±1.0 g/dL respectively. There was no significant difference found in 
this study [6]. According to the study conducted by Hartfield et al, there 
was no significant difference between two groups (11.7 vs 11.6)[67]. 
Mean MCV levels in cases and controls were 68.7 ± 6.3 and 76.5 ± 
6.5 respectively. The difference between the two groups were statistically 
significant (p-value <0.0001). Highest MCV value was 82.8 fl and lowest 
value 52.8 fl. According to Hartfield et al, mean MCV levels were 
significantly lower when compared with controls (76.6 vs 77.8)[67]. 
According to Leelakumari et al, mean MCV levels were lower but it was 
not statistically significant[6]. Ghasem et al conducted a study in Iran and 
found that mean MCV levels in cases and controls were 78.14±7.35 and 
79.63±5.40fl respectively[66]. 
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Mean MCHC levels in cases and controls were 33.1 ± 1.4 and 33.6 ± 1.1 
% respectively. There was no statistical significance (p-value 0.062). Ghasem et 
al found that mean MCHC values were 31.46±1.76 and 31.78±1.24 % 
respectively[66]. 
Mean MCH levels in cases and controls were 22.8 ± 2.4 and 26 ± 2.6 
respectively. The difference between the two groups was statistically significant 
(p-value <0.001). leelakumari et al found out that there were relatively low red 
cell indices when compared with controls[6].   
Mean RDW levels in cases and controls were 16.1 ± 1.6 and 14.3 ± 1.5 
respectively. The mean RDW levels were significantly higher in cases when 
compared with controls (p-value <0.0001). Leelakumari et al found out that 
Mean RDW values were significantly higher when compared with 
controls[6].According to Hartfield et al mean RDW levels in cases and controls 
were 14 and 13.9 respectively[67]. Hassan et al found that mean RDW levels in 
cases and controls were 16.8 ± 1.3 and 12.7 ± 1.1 respectively. The difference is 
statistically significant[65]. 
In this study we also compared between Mean levels of zinc, 
haemoglobin, MCV, MCHC, MCH, RDW in < 24 months and > 24 months age 
group separately. We found out that serum zinc levels were almost similar in 
both groups. There was comparatively lower mean levels of Iron, MCV, 
MCHC, RDW in < 24 months group than >24 months group.  
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Odds ratio for development of febrile seizures was more, if they were 
having both low Iron and Zinc levels. If they were having either low Iron or 
Zinc, there was no increased risk when compared with controls.  
 
Limitations of the study:  
1) It was a relatively smaller and hospital based study, a larger study is 
required to confirm these findings. 
2) Serum ferritin levels could not be measured due to financial 
constraints.  
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CONCLUSIONS 
1) Iron and zinc levels were significantly low in children with febrile 
seizures when compared to febrile children without seizures. 
2) Serum Iron was very much low in children < 2years of age when 
compared to > 2years of age. 
3) There is no age wise difference in mean Zinc levels. 
4) There was 68.3 times increased risk of developing seizures, if they were 
having both low Iron and Zinc levels.  
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RECOMMENDATIONS 
 
• The study supports the existing relationship between low Iron and zinc 
levels with febrile seizures 
• Supplementation of Iron and Zinc may be helpful to prevent recurrence of 
febrile seizures. 
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ABBREVATIONS 
AAP          -       American Academy of Paediatrics 
  ILAE         -       International League against Epilepsy 
  NIH           -       National Institute of Health  
  NICU        -       Neonatal Intensive Care Unit 
  GEFS+      -       Generalised Epilepsy Febrile Seizures Plus 
 MMR        -       Measles, Mumps, Rubella 
 DPT           -       Diphtheria, Pertussis, Tetanus 
 TIV            -       Trivalent Influenza Vaccine 
  LAIV        -        Live Attenuated Influenza Vaccine 
 ACIP         -        Advisory Committee on Immunisation practices 
 HHV-6      -        Human Herpes Virus 6 infection 
 RSV          -         Respiratory syncytial Virus 
 GABA      -          Gamma-Amino Butyric Acid 
 IL-1β         -         Interleukin 1β 
NMDA       -         N-Methyl-D-Aspartate receptor 
EEG           -         Electro Encephalogram 
CNS           -         Central Nervous System 
CSF           -          Cerebro Spinal Fluid 
Hb             -          Haemoglobin 
MCV         -          Mean Corpuscular Volume 
MCH         -          Mean Corpuscular Haemoglobin 
MCHC      -          Mean Corpuscular Haemoglobin Concentration 
RDW        -          Red cell Distribution Width 
WHO        -          World Health Organization 
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SUBHASH 13/20180 1 Y 1 24 1 100.8 NO 1 14 1 5 10 1 74.86 51.3 9 68.8 32 21.8 15.3 
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AMUTHA'S BABY 13/20722 3 N 1 14 1 100.2 NO 2 10 1 5 9.1 1 34.5 43 10 72.6 32.5 23.6 16.5 
VINOTHINI'S BABY 13/21335 4 N 1 16 2 102 NO 2 14 1 5 8.9 1 156.2 128 11.9 81.2 33.4 27.1 13.4 
PRANESH 13/21419 2 N 1 12 1 100 NO 2 15 2 4 10.3 1 28.4 19.4 10.3 62.3 31 19.3 16.7 
JESURAN 13/21758 3 N 1 18 1 104 NO 2 12 1 3 9.8 1 20.38 49.4 10.5 66 31.5 20.8 16.1 
SHANTHINI O13052158 1 Y 1 24 2 102 NO 1 16 1 3 9.6 2 59.2 58.1 9.6 65 30.4 20.6 16.2 
YUGITHA 13/22703 1 Y 1 30 2 101.5 NO 1 20 2 4 11.5 1 28.2 34.2 10.6 64.5 32.6 22.9 16.3 
SHARMILA BANU'S BABY 13/22939 3 N 1 18 1 100.6 NO 2 22 1 5 8.7 2 41.4 53.88 10.9 82.2 32.3 26.5 15.8 
SATHYAPRASAD 13/23047 1 Y 1 60 1 100.8 NO 1 12 1 2 20 1 141.9 66 14.2 83.5 32.1 26.8 12.8 
RAGHAVENDRA 13/23254 1 Y 1 18 1 100 NO 2 14 2 5 9.8 1 56.2 34.3 11 68 32.9 24.3 15.1 
TAMILARASI 13/23760 4 N 1 10 2 100 NO 1 22 1 2 8.5 1 58.5 156 10.9 82.8 32.9 27.3 13.4 
B/O GOWRI 13/24396 3 N 1 20 2 100.6 NO 1 20 2 2 11 1 56.2 19 11 69 34.7 24.3 15.4 
VIGHASE 13/24822 1 Y 1 18 1 101.2 NO 2 12 2 5 9 1 156 42 8.7 67.9 32.3 21.9 20.8 
MAHESWARI'S BABY 13/24846 1 N 1 6 1 100.6 NO 1 14 1 5 7 1 52.6 51 10.2 67.3 31.2 22.2 18.1 
SATHISH 13/24831 3 Y 1 48 1 101 NO 2 10 1 4 15 1 22.56 34 10.1 66.9 32.5 21 16.7 
SAMVEL SATHYA 13/24954 1 Y 1 24 1 102 NO 2 22 1 5 12 1 26.5 19 10.9 66.3 32.7 21.7 17.5 
SAADHANA 13/25129 1 N 1 48 2 100 NO 1 10 1 5 12.4 2 138.4 186 12.1 81.6 32.4 26.4 13.9 
B/O SELVI 13/25273 1 N 1 10 1 104 NO 2 14 1 5 7.7 1 91.8 13 10.8 68 32.6 24.9 15.1 
CHITRA'S BABY 13/26304 1 N 1 24 2 100.6 NO 2 12 1 4 9 2 22.6 53 11 69 31.9 24.2 15.2 
PRIYA'S BABY 13/27095 1 N 1 18 2 103 NO 2 14 1 5 14 1 51 17 10.5 67 30.8 24.3 16.2 
JINIYA 13/28986 1 N 1 24 2 102 NO 2 16 1 2 9.5 2 31.6 57.12 10.2 68.6 34 21.5 17.4 
KIRISHIKA 13/31099 1 N 1 11 2 101 NO 1 12 1 2 7.6 2 116.1 52 11 69 35.8 25.6 15.4 
B/O RAJESWARI 13/32419 4 Y 1 12 2 104 NO 1 14 2 5 11 1 49.5 16 10.8 68.6 34 25.4 15.6 
B/O JAYANTHI 13/33217 1 N 1 18 1 101 NO 2 16 1 5 8.5 2 128 19.4 10.4 69.7 31.2 21.8 17.7 
SANTHOSH.V 13/33919 4 Y 1 36 1 103 NO 2 16 1 4 12.7 1 56.5 124 12.1 79.3 31.1 24.7 15 
SRIVIKASH 13/34543 2 N 1 24 1 103 NO 2 14 2 4 11.1 1 14 22 9 60.4 32.8 19.8 19.8 
SREERAM 13/36423 2 NA 2 6 1 100 NO 2 NA NA 5 11 1 111.4 98 11.5 75.2 36 27.8 14.3 
ASHWIN 13/36904 2 N 1 24 1 104 NO 2 14 1 5 12.5 1 57.6 30.7 10.7 68.2 32.3 21.1 16.8 
PREETHI 13/37305 2 NA 2 14 2 102 NO 2 NA NA 5 7.4 2 45.33 57 10.2 66.1 33.5 22.1 17.1 
SANTHOSH.T 13/37666 4 NA 2 60 1 104 NO 2 NA NA 4 16 1 120.5 82.9 11.6 75.2 34.2 28.5 13.4 
RANJANI 13/37680 2 N 1 18 2 101.2 NO 2 14 1 4 10 1 90 49.6 10.2 69.3 34.5 23.7 15.6 
DHARUN AKASH 13/37751 4 NA 2 48 1 102 NO 2 NA NA 5 15.6 1 98.2 87.6 11.2 78.3 33.1 25.9 13.8 
BHAVANIKA 13/37761 3 NA 2 22 2 101.2 NO 2 NA NA 5 9.3 2 97.1 58.7 10.5 63.2 31.7 20 16.2 
KALPANA'S BABY 13/38668 1 N 1 12 2 102.5 NO 2 12 1 5 9.5 1 23.38 29.7 10.6 69.1 33.7 23.3 17.9 
VIJI'S BABY 14/00234 2 NA 2 24 2 101 NO 2 NA NA 4 9.4 2 123.5 46 9.6 58.5 32.8 19.2 19.7 
JAYASHREE'S BABY 14/00478 1 N 1 36 1 104 NO 2 12 2 2 14 1 24.5 78 12.1 76.7 34.2 26.2 13.2 
SALVIN KIRBA 14/00652 2 NA 2 10 1 103 NO 2 NA NA 5 7.9 1 102.8 89.2 11.7 79.3 32.1 27.2 13.3 
MAHASRI 14/00291 4 NA 2 10 1 102 NO 2 NA NA 4 10 1 98.3 87.5 11.6 77.8 33.5 28.5 14.3 
ARYA RANJITH 14/00643 1 N 1 24 1 103 NO 2 10 1 2 12.5 1 57.6 20 10.2 68.6 33 22.6 19.3 
ANUSHREE O13037625 3 Y 1 12 2 103 NO 2 8 1 5 10.5 1 26.8 46.6 10.3 66 32 18.8 18.1 
SHARUMATHI 14/09294 1 N 1 15 2 100.4 NO 2 10 2 5 11 1 16 27 10.9 63.6 32.7 20.8 16.6 
ANTHONY STELLA'S BABY 14/09955 4 N 1 11 1 101 NO 2 12 1 5 8 1 44.3 153.4 11.9 74.3 32.1 23.9 14.4 
POORNIMA'S BABY 14/12633 4 NA 2 6 1 100.2 NO 2 NA NA 4 7 1 79.05 90.5 11.6 72.6 33.4 24.2 13 
HASHINI 14/12756 1 Y 1 36 2 100 NO 2 4 1 2 10.5 2 22.4 56.4 10.6 52.8 34.7 18.2 18.3 
DAKSHATHA 14/13001 4 Y 1 18 2 100.8 NO 2 12 1 5 10.2 1 47.6 48.5 9.6 62.4 35 20.3 16.1 
MADHAV 14/13068 3 NA 2 36 1 101 NO 2 NA NA 2 10.2 2 152.6 87.5 11.6 81.8 34.3 28 13.7 
SARSHANA 14/14628 1 N 1 12 2 101 NO 2 12 1 2 10 1 25.6 53.7 10.4 63.3 34.5 20.2 16.7 
VIDHYUTHA 14/14640 1 N 1 12 2 102 NO 2 14 1 1 8 1 18.79 45.56 9.1 55.3 34.3 19 16.9 
SHANTHI'S BABY 14/16027 1 N 1 36 1 101 NO 2 4 1 5 15.8 1 24.5 34.46 10.8 69 35.8 19.8 15.4 
SHITTESH 14/18122 4 NA 2 60 1 101.2 NO 2 NA NA 5 18.8 1 201.4 111.5 11.3 81.5 34.6 28.2 13.1 
NEELAVATHI'S BABY 14/18335 1 N 1 24 1 100.6 NO 2 4 1 5 10.7 1 16.07 56.5 10.8 68.6 35.2 25.3 15.2 
ASHWATHI 14/18406 3 NA 2 48 2 100 NO 2 NA NA 2 13.6 1 78.2 87.5 11.3 79.5 34.3 27.3 13.7 
ASHISH YUVIN 14/18476 2 NA 2 36 1 100.8 NO 2 NA NA 1 14.6 1 94 87.6 12 75.5 33.8 26.5 15.1 
JOHN ROBIN 14/18413 2 NA 2 36 1 101.4 NO 2 NA NA 5 18.5 1 102 85.2 13.1 91.3 34.8 31.8 13.8 
KAVIYA 14/18969 1 NA 2 18 1 101 NO 2 NA NA 2 11 1 78.4 94 13.3 81.7 33.7 27.5 13.6 
NAREN KARTHIKEYAN 14/18780 4 NA 2 22 1 101 NO 2 NA NA 2 12 1 82.88 97.5 11.2 77.1 33.5 25.8 14.6 
DEEPA'S BABY 14/18775 2 NA 2 24 1 101.4 NO 2 NA NA 5 11.7 1 156 118 11.7 71.9 33.9 26.1 15.1 
DHARAN KUMAR 14/18927 1 NA 2 8 1 101.6 NO 2 NA NA 5 7.62 1 118 31 9.6 65.7 32.7 21.5 16.2 
SHRIMATHI 14/19091 1 NA 2 28 2 100.8 NO 2 NA NA 5 13 1 95.6 87.6 11.6 88.1 36 27.1 13.3 
KALAMANI'S BABY 14/19211 3 NA 2 12 2 100.9 NO 2 NA NA 4 8 1 145 138.4 11.9 78.2 34.2 25.3 14.2 
JERON.E 14/19350 2 NA 2 8 1 100.6 NO 2 NA NA 3 8.3 1 81.2 86 11.8 71.6 33.1 25.7 14.5 
KAMALESWARAN 14/19345 3 NA 2 48 1 100.2 NO 2 NA NA 3 13 1 82.4 87.5 12.8 78 33 25.8 14 
RITHIKA 14/19645 2 NA 2 24 2 100.4 NO 2 NA NA 4 11.6 1 94.6 102.5 12.9 79.1 34.7 27.4 14.6 
HARSHIKASRI 14/19749 1 NA 2 9 2 102 NO 2 NA NA 2 7.8 1 87.5 78.4 12.3 71.9 34.8 25.8 14.7 
KAMALESH KUMARAN 14/19743 4 NA 2 24 1 100.4 NO 2 NA NA 3 11.4 1 105 109.6 11.2 74.3 34.9 26.7 13.6 
KAMALASH 14/20146 1 Y 1 48 1 101.4 NO 2 4 1 3 14.5 1 58.2 42.3 10.8 69.7 34.8 24.3 16.3 
SREE VIKASH 14/20135 2 Y 1 36 1 100.6 NO 2 6 1 4 14.5 1 34.3 41.4 10.6 68.3 34.3 23.3 15.9 
BENAZIR PARVEEN 14/20196 3 NA 2 8 2 101 NO 2 NA NA 5 6.16 2 77.5 72.55 11.4 78.4 35.4 27.4 13.4 
GUHAN 14/20275 4 NA 2 27 1 101.6 NO 2 NA NA 5 13 1 74.86 72.9 11.7 81 35.5 28.7 13.3 
REDHU 14/20338 1 N 1 18 2 100 NO 2 10 1 4 10 1 16.22 23 10.6 63.5 35.3 22.3 16.3 
RANJITH PRASATH 14/20352 2 Y 1 36 1 100.6 NO 2 4 1 3 15 1 42.15 58.92 10.9 68 35.5 23.4 15.5 
B/O NITHYA 14/20533 1 NA 2 6 1 100.2 NO 2 NA NA 4 6.4 1 101.5 73.5 11.7 92.5 34.3 31.7 14.3 
USHA'S BABY 14/20586 1 N 1 26 2 102 NO 2 20 1 5 11 1 36.8 47.6 10.5 65.5 33.6 24.2 15.3 
VISHWA 14/20331 2 NA 2 11 1 100 NO 2 NA NA 3 7.5 2 130.8 89.84 11.9 72.3 33.1 25.3 14.8 
SHOBHA'S BABY 14/20574 1 NA 2 24 1 100.4 NO 2 NA NA 2 13 1 141.9 79.5 12.5 79.3 33.4 26.5 13.1 
NAKSHATRA 14/20751 5 NA 2 12 2 101.2 NO 2 NA NA 4 11 1 103.5 84.06 12.3 78.3 35.5 26.7 13.2 
SASTIKA 14/20781 3 NA 2 12 2 101 NO 2 NA NA 4 10.5 1 106.6 62.5 9.5 63.4 31.3 19.9 18.8 
SARAN 14/20687 4 NA 2 48 1 100.6 NO 2 NA NA 5 15.5 1 109.5 72.8 12.5 76.1 32.6 27.5 14.5 
KAMALIKA 14/21010 3 Y 1 48 2 104 NO 2 4 1 5 13 1 15.4 23 8.6 67 32 22.2 16.4 
DHILIP 14/21077 4 NA 2 36 1 101 NO 2 NA NA 5 14 1 116.2 92.6 12.8 79.6 33 26.3 14 
ANCHANAAKSHI 14/21171 5 N 1 11 2 102.5 NO 1 4 1 4 7.5 2 19.9 55.8 10.8 69.3 34.2 22.9 15.9 
PRASANNA 14/21335 2 NA 2 28 1 100.5 NO 2 NA NA 4 12.3 1 96.7 110.8 12 82.9 32.6 27 13.7 
B/O MEENAKSHI 14/22533 2 Y 1 10 1 100.3 NO 2 10 1 5 7.7 2 18.5 36.2 11 69.4 33.6 23.7 14.6 
B/O SAHANA 14/22287 4 NA 2 18 1 101.2 NO 2 NA NA 5 9.3 1 40.5 67 11.8 73.4 33.3 25.5 12.5 
PRAJESH 14/22543 4 NA 2 26 1 101.2 NO 2 NA NA 5 11 2 75 69 12.1 77.6 33.7 26.2 14.2 
PRIYA'S BABY 14/23879 2 NA 2 6 1 101 NO 2 NA NA 4 7.5 1 58.6 98.4 11.7 71.6 33.9 23.3 13.4 
MANOJ KUMAR 14/23890 2 NA 2 60 1 102 NO 2 NA NA 4 18 1 56.8 67.4 11.4 78.4 33.7 26.4 12.3 
RITHIK 14/24063 1 NA 2 18 1 102 NO 2 NA NA 3 9.4 1 46.8 56.8 10.7 68.8 30.5 21.3 16.7 
RENUGA'S BABY 14/24524 1 NA 2 36 2 101.2 NO 2 NA NA 5 10.7 2 92.6 88.8 11.4 81.7 33.3 27.3 12.7 
SUMATHI'S BABY 14/24700 3 NA 2 11 1 102.4 NO 2 NA NA 4 9 1 78.6 72.8 12.1 84.9 33.3 28.3 14.4 
PRADEEPA 14/24538 2 NA 2 36 2 100.8 NO 2 NA NA 5 12.5 1 49.2 71.28 11.7 77.3 32 26.5 13.4 
NAKSHATRA 14/25439 3 NA 2 12 2 103.4 NO 2 NA NA 4 11.5 1 40.08 75.9 11.5 72.3 33.2 24 12.7 
KALAISELVI'S BABY 14/25462 2 NA 2 6 2 100.1 NO 2 NA NA 3 5.75 2 86.2 92.6 11.4 78.6 32.9 25.8 14.2 
RUTHITA.R 14/25357 2 NA 2 9 2 102 NO 2 NA NA 4 7.1 1 78.5 68.5 11.9 75.5 32.6 24.6 15.5 
FAHIMA FARZEEN 14/25285 2 NA 2 24 2 101 NO 2 NA NA 5 11.9 1 46.8 66.5 11.5 76.5 32.8 23.8 16.5 
MOHAMMED ALTHAF 14/25222 2 NA 2 24 1 100.1 NO 2 NA NA 5 9.2 2 86.5 80.6 11.4 69.8 33 26.8 15.8 
AMSALATHA'S BABY 14/25573 1 NA 2 6 1 101.4 NO 2 NA NA 5 7.2 1 60.1 67.3 11.5 79.8 33.3 26.6 13.3 
 
 
